Golo Ahlenstiel Selected Research

Golo Ahlenstiel Research Topics

Disease

28	Infections 01/2022 - 06/2004
13	Hepatitis C 01/2014 - 06/2002
12	Chronic Hepatitis C 01/2021 - 08/2003
10	Virus Diseases (Viral Diseases) 01/2021 - 03/2008
6	Fibrosis (Cirrhosis) 11/2021 - 02/2016
6	Liver Diseases (Liver Disease) 01/2021 - 08/2003
5	Neoplasms (Cancer) 08/2021 - 01/2015
4	Inflammation (Inflammations) 10/2021 - 01/2019
4	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019 - 03/2015
3	Persistent Infection 01/2021 - 01/2005
3	HIV Infections (HIV Infection) 01/2015 - 12/2005
3	Coinfection 01/2015 - 12/2005
2	Reinfection 01/2022 - 04/2020
2	Portal Hypertension 11/2021 - 10/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 10/2013
2	Hemorrhage 01/2021 - 10/2015
1	Body Weight (Weight, Body) 11/2021
1	Liver Neoplasms (Liver Cancer) 10/2021
1	Colorectal Neoplasms (Colorectal Cancer) 08/2021
1	Adenoma (Adenomas) 01/2021
1	Polyps 01/2021
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2021
1	Chronic Hepatitis B 01/2021
1	Necrosis 01/2021
1	Common Cold 01/2019
1	Diarrhea 10/2018
1	Chronic Disease (Chronic Diseases) 01/2017
1	Human Influenza (Influenza) 01/2017
1	Thrombosis (Thrombus) 10/2015
1	Melena 10/2015
1	Stomach Ulcer (Gastric Ulcer) 10/2015
1	Varicose Veins (Varicose Vein) 10/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2015
1	Deglutition Disorders (Dysphagia) 01/2015
1	Bacterial Infections (Bacterial Infection) 01/2015
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Weight Loss (Weight Reduction) 01/2015
1	Sepsis (Septicemia) 01/2015
1	Insulin Resistance 11/2013
1	RNA Virus Infections 10/2009
1	Autoimmune Hepatitis 12/2008

Drug/Important Bio-Agent (IBA)

18	Antiviral Agents (Antivirals)IBA 01/2021 - 08/2003
15	InterferonsIBA 01/2021 - 08/2003
9	Ribavirin (Virazole)FDA LinkGeneric 10/2014 - 08/2003
6	Interferon-alpha (Interferon Alfa)IBA 12/2013 - 08/2003
5	AntigensIBA 01/2022 - 12/2008
5	Interferon LambdaIBA 10/2019 - 08/2014
4	VaccinesIBA 01/2022 - 04/2020
4	CytokinesIBA 01/2021 - 01/2009
4	CCR5 Receptors (CCR5 Receptor)IBA 01/2009 - 06/2002
3	Immune Checkpoint InhibitorsIBA 08/2021 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2020 - 08/2011
3	ZincIBA 01/2019 - 01/2017
2	Capsules (Microcapsules)IBA 01/2021 - 10/2015
2	Monoclonal AntibodiesIBA 01/2020 - 01/2019
2	IronIBA 01/2019 - 10/2018
2	InterleukinsIBA 01/2012 - 09/2010
1	Broadly Neutralizing AntibodiesIBA 01/2022
1	EnzymesIBA 11/2021
1	amsonic acid (DAS)IBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Hepatitis B Core AntigensIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021
1	lenvatinibIBA 01/2021
1	atezolizumabIBA 01/2021
1	Fungal AntigensIBA 10/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Vitamin A (Retinol)FDA LinkGeneric 01/2019
1	MicronutrientsIBA 01/2019
1	LectinsIBA 01/2019
1	CopperIBA 01/2019
1	SeleniumIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	AntioxidantsIBA 01/2019
1	Pepsinogen A (Pepsinogen)IBA 10/2018
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 10/2018
1	Genetic Markers (Genetic Marker)IBA 02/2016
1	factor V LeidenIBA 10/2015
1	OligonucleotidesIBA 01/2015
1	HLA-A Antigens (HLA-A)IBA 01/2015
1	HLA-B57 antigenIBA 01/2015
1	LipidsIBA 11/2013
1	Interferon-gamma (Interferon, gamma)IBA 01/2012
1	HLA-C Antigens (HLA-C)IBA 09/2011
1	Methionine (L-Methionine)FDA Link 03/2011
1	GoldIBA 09/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010
1	LigandsIBA 01/2010
1	LDL Receptors (LDL Receptor)IBA 09/2009
1	NucleotidesIBA 09/2009
1	HLA-DRB1*03:01 antigenIBA 12/2008

Therapy/Procedure

25	Therapeutics 08/2021 - 07/2008
2	Liver Transplantation 11/2021 - 10/2013
1	Immunomodulation 04/2020
1	Argon Plasma Coagulation 10/2015
1	Highly Active Antiretroviral Therapy (HAART) 01/2015
1	Gastrostomy 01/2015
1	Nutritional Support (Artificial Feeding) 01/2015
1	Chemoradiotherapy 01/2015